Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Dense deposit disease, a histological subtype of MPGN is an idiopathic chronic progressive kidney disorder distinguished by the presence of intra-membranous dense deposits in addition to immune complex subendothelial deposits in the glomerular capillary walls. This form often has a higher recurrence rate after a kidney transplant and is associated with extra-renal manifestations such as familial drusen.
Biomarker and diagnostic research for dense deposit disease has been reported in the published literature.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
4 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
48 publications have been identified in PubMed for dense deposit disease. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (17%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 11:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 8 | 17% |
Disease patterns and progression | 8 | 17% |
Laboratory research | 4 | 8% |
Other research | 3 | 6% |
Testing and diagnosis research | 3 | 6% |
Clinical study results | 3 | 6% |
New treatment approaches | 1 | 2% |
Kunisho Y (2026). [PMID: 41642467](https://pubmed.ncbi.nlm.nih.gov/41642467/). *CEN Case Rep*. [Case Report / Case Series]
Sethi S (2026). [PMID: 41895686](https://pubmed.ncbi.nlm.nih.gov/41895686/). *Kidney Int*. [Epidemiology / Natural History]
Ayehu G (2026). [PMID: 39536144](https://pubmed.ncbi.nlm.nih.gov/39536144/). *Unknown Journal*. [Review / Meta-Analysis]
Filippone EJ (2026). [PMID: 41767602](https://pubmed.ncbi.nlm.nih.gov/41767602/). *Frontiers in nephrology*. [Review / Meta-Analysis]
Kunisho Y (2026). [PMID: 41874886](https://pubmed.ncbi.nlm.nih.gov/41874886/). *CEN Case Rep*. [Other]
Mashayekhi M (2026). [PMID: 41783430](https://pubmed.ncbi.nlm.nih.gov/41783430/). *Kidney medicine*. [Case Report / Case Series]
Praga M (2026). [PMID: 41921739](https://pubmed.ncbi.nlm.nih.gov/41921739/). *Am J Kidney Dis*. [Review / Meta-Analysis]
Chang X (2026). [PMID: 41866222](https://pubmed.ncbi.nlm.nih.gov/41866222/). *Nephrology (Carlton)*. [Case Report / Case Series]
Kawasaki Y (2026). [PMID: 40993076](https://pubmed.ncbi.nlm.nih.gov/40993076/). *Fukushima J Med Sci*. [Case Report / Case Series]
Dixit S (2026). [PMID: 41208293](https://pubmed.ncbi.nlm.nih.gov/41208293/). *Current opinion in nephrology and hypertension*. [Review / Meta-Analysis]